RedHill Biopharma Ltd.

NASDAQ: RDHL · Real-Time Price · USD
1.37
-0.02 (-1.44%)
At close: Aug 15, 2025, 3:59 PM
1.39
1.36%
After-hours: Aug 15, 2025, 06:45 PM EDT

RedHill Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-8.27M 23.92M -71.67M -97.74M
Depreciation & Amortization
619K 1.99M 8.15M 18.15M
Stock-Based Compensation
665K 1.65M 5.67M 10.21M
Other Working Capital
3.37M -50.44M 14.49M 10.04M
Other Non-Cash Items
-4.44M -47.79M 20.65M 5.37M
Deferred Income Tax
n/a n/a n/a 123K
Change in Working Capital
2.05M -15.58M 8.01M -1.15M
Operating Cash Flow
-9.37M -35.82M -29.18M -65.05M
Capital Expenditures
-9K -11K -198K -115K
Cash Acquisitions
n/a n/a n/a 8.03M
Purchase of Investments
n/a n/a n/a -8.5M
Sales Maturities Of Investments
n/a 14.96K 8.5M 475K
Other Investing Acitivies
n/a -0.31 8.5M -8.03M
Investing Cash Flow
-9K 3.99K 8.3M -8.14M
Debt Repayment
-636K n/a -1.48M -1.68M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
790K 7.46M -10.88M -3.39M
Financial Cash Flow
8.42M 21.38M 11.45M 73.46M
Net Cash Flow
-952K -14.4M -9.51M 179K
Free Cash Flow
-9.38M -35.83M -29.38M -65.16M